Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Bionano Genomics Inc (BNGO) USD0.0001

Sell:$5.63 Buy:$5.63 Change: $0.45 (7.37%)
Market closed |  Prices as at close on 16 April 2021 | Switch to live prices |
Sell:$5.63
Buy:$5.63
Change: $0.45 (7.37%)
Market closed |  Prices as at close on 16 April 2021 | Switch to live prices |
Sell:$5.63
Buy:$5.63
Change: $0.45 (7.37%)
Market closed |  Prices as at close on 16 April 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Bionano Genomics, Inc. is a life sciences instrumentation company in the genome analysis space. The Company develops and markets the Saphyr system. The Company’s products include Sequencing for Discovery Research and Cytogenetics. Cytogenetics provide a clinical diagnosis, cytogenetic tests detect known variations that are linked to specific diseases or therapeutic responses. Saphyr system is platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. Sequencing for Discovery Research is primarily used to find single nucleotide variations responsible for disease or therapeutic response. The Company’s subsidiary, Lineagen, Inc., provides molecular diagnostics services for individuals.

Contact details

Address:
9540 Towne Centre Dr Ste 100
SAN DIEGO
92121-1989
United States
Telephone:
+1 (858) 8887600
Website:
https://bionanogenomics.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
BNGO
ISIN:
US09075F1075
Market cap:
$1.79 billion
Shares in issue:
278.66 million
Sector:
Life Sciences Tools & Services
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • David Barker
    Independent Chairman of the Board
  • R. Erik Holmlin
    President, Chief Executive Officer, Director
  • Christopher Stewart
    Chief Financial Officer
  • Mark Oldakowski
    Chief Operating Officer
  • Alka Chaubey
    Chief Medical Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.